These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8450103)

  • 1. Influence of psychoactive substance use on the reliability of psychiatric diagnosis.
    Corty E; Lehman AF; Myers CP
    J Consult Clin Psychol; 1993 Feb; 61(1):165-70. PubMed ID: 8450103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of mental and substance use disorders. A comparison of single and dual diagnosis patients.
    Lehman AF; Myers CP; Thompson JW; Corty E
    J Nerv Ment Dis; 1993 Jun; 181(6):365-70. PubMed ID: 8388914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of substance use disorders among psychiatric inpatients.
    Lehman AF; Myers CP; Dixon LB; Johnson JL
    J Nerv Ment Dis; 1996 Apr; 184(4):228-33. PubMed ID: 8604032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of substance use disorders among psychiatric inpatients.
    Lehman AF; Myers CP; Corty E; Thompson J
    J Nerv Ment Dis; 1994 Mar; 182(3):164-7. PubMed ID: 8113777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers.
    Hasin DS; Trautman KD; Miele GM; Samet S; Smith M; Endicott J
    Am J Psychiatry; 1996 Sep; 153(9):1195-201. PubMed ID: 8780425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance use and other psychiatric disorders among 100 American Indian patients.
    Westermeyer J; Neider J; Westermeyer M
    Cult Med Psychiatry; 1992-1993; 16(4):519-29. PubMed ID: 1305530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High interrater reliability for the Structured Clinical Interview for DSM-III-R Axis I (SCID-I).
    Skre I; Onstad S; Torgersen S; Kringlen E
    Acta Psychiatr Scand; 1991 Aug; 84(2):167-73. PubMed ID: 1950612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders.
    Wilens TE; Biederman J; Mick E; Faraone SV; Spencer T
    J Nerv Ment Dis; 1997 Aug; 185(8):475-82. PubMed ID: 9284860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of dual diagnosis. Substance dependence and psychiatric disorders.
    Bryant KJ; Rounsaville B; Spitzer RL; Williams JB
    J Nerv Ment Dis; 1992 Apr; 180(4):251-7. PubMed ID: 1556565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal, expert, all data procedure for psychiatric diagnosis in patients with psychoactive substance use disorders.
    Kranzler HR; Kadden RM; Babor TF; Rounsaville BJ
    J Nerv Ment Dis; 1994 May; 182(5):277-83. PubMed ID: 10678309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV.
    Hasin D; Samet S; Nunes E; Meydan J; Matseoane K; Waxman R
    Am J Psychiatry; 2006 Apr; 163(4):689-96. PubMed ID: 16585445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norms and sensitivity of the adolescent version of the drug use screening inventory.
    Kirisci L; Mezzich A; Tarter R
    Addict Behav; 1995; 20(2):149-57. PubMed ID: 7484309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of the SCID in substance abuse patients.
    Kranzler HR; Kadden RM; Babor TF; Tennen H; Rounsaville BJ
    Addiction; 1996 Jun; 91(6):859-68. PubMed ID: 8696248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing substance use in multiproblem patients: reliability and validity of the Addiction Severity Index in a mental hospital population.
    Appleby L; Dyson V; Altman E; Luchins DJ
    J Nerv Ment Dis; 1997 Mar; 185(3):159-65. PubMed ID: 9091597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV.
    Torrens M; Serrano D; Astals M; Pérez-Domínguez G; Martín-Santos R
    Am J Psychiatry; 2004 Jul; 161(7):1231-7. PubMed ID: 15229056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining subgroups of dual diagnosis patients for service planning.
    Lehman AF; Myers CP; Dixon LB; Johnson JL
    Hosp Community Psychiatry; 1994 Jun; 45(6):556-61. PubMed ID: 8088734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and patterns of "dual diagnosis" among psychiatric inpatients.
    Lehman AF; Myers CP; Corty E; Thompson JW
    Compr Psychiatry; 1994; 35(2):106-12. PubMed ID: 8187473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mental and behavioural disorders due to use of psychoactive substances (F1). Results from the ICD-10 field trial of the Diagnostic Criteria for Research in German-speaking countries.
    Müssigbrodt H; Dilling H; Dittmann V; Meszaros K
    Psychopathology; 1996; 29(5):274-9. PubMed ID: 8936605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Composite International Diagnostic Interview and clinical DSM-III-R criteria checklist diagnoses.
    Janca A; Robins LN; Bucholz KK; Early TS; Shayka JJ
    Acta Psychiatr Scand; 1992 Jun; 85(6):440-3. PubMed ID: 1642126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent validity of clinicians' ratings of substance abuse among psychiatric outpatients.
    Carey KB; Cocco KM; Simons JS
    Psychiatr Serv; 1996 Aug; 47(8):842-7. PubMed ID: 8837156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.